Valeo Financial Advisors, LLC Amgen Inc Transaction History

Valeo Financial Advisors, LLC

$3.81 Billion
Q3 2024

A detailed history of Valeo Financial Advisors, LLC transactions in Amgen Inc stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 42,910 shares of AMGN stock, worth $12.4 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

42,910

Previous 43,895 2.24%

Holding current value

$12.4 Million

Previous $13.7 Million 0.82%

% of portfolio

0.36%

Previous 0.39%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$309.38 - $337.38 $304,739 - $332,319	-985 Reduced 2.24%	42,910 $13.8 Million
Q2 2024 Jul 10, 2024	SELL	$262.75 - $319.31 $261,436 - $317,713	-995 Reduced 2.22%	43,895 $13.7 Million
Q1 2024 Apr 25, 2024	SELL	$268.87 - $324.56 $51,354 - $61,990	-191 Reduced 0.42%	44,890 $12.8 Million
Q1 2024 Apr 19, 2024	SELL	$268.87 - $324.56 $412,715 - $498,199	-1,535 Reduced 3.29%	45,081 $12.8 Million
Q4 2023 Jan 29, 2024	BUY	$255.7 - $288.46 $134,242 - $151,441	525 Added 1.14%	46,616 $13.4 Million
Q3 2023 Oct 19, 2023	BUY	$218.65 - $271.46 $145,620 - $180,792	666 Added 1.47%	46,091 $12.4 Million
Q2 2023 Jul 14, 2023	BUY	$214.27 - $253.37 $606,169 - $716,783	2,829 Added 6.64%	45,425 $10.1 Million
Q1 2023 Apr 17, 2023	BUY	$225.79 - $275.2 $561,313 - $684,147	2,486 Added 6.2%	42,596 $10.3 Million
Q4 2022 Feb 09, 2023	BUY	$229.03 - $291.01 $311,709 - $396,064	1,361 Added 3.51%	40,110 $10.5 Million
Q3 2022 Oct 31, 2022	BUY	$224.46 - $253.15 $216,154 - $243,783	963 Added 2.55%	38,749 $3.69 Million
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $141,425 - $157,381	-613 Reduced 1.6%	37,786 $3.75 Million
Q1 2022 Apr 28, 2022	BUY	$219.27 - $242.57 $310,705 - $343,721	1,417 Added 3.83%	38,399 $3.88 Million
Q4 2021 Jan 07, 2022	SELL	$198.88 - $227.6 $291,160 - $333,206	-1,464 Reduced 3.81%	36,982 $3.29 Million
Q3 2021 Nov 02, 2021	BUY	$212.27 - $248.7 $320,739 - $375,785	1,511 Added 4.09%	38,446 $3.42 Million
Q2 2021 Jul 22, 2021	BUY	$233.58 - $259.14 $138,045 - $153,151	591 Added 1.63%	36,935 $3.55 Million
Q1 2021 Apr 12, 2021	BUY	$221.91 - $258.6 $18,196 - $21,205	82 Added 0.23%	36,344 $3.48 Million
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $5.09 Million - $6.06 Million	23,531 Added 184.83%	36,262 $3.2 Million
Q3 2020 Oct 28, 2020	SELL	$234.65 - $260.95 $213,531 - $237,464	-910 Reduced 6.67%	12,731 $3.24 Million
Q2 2020 Jul 20, 2020	BUY	$197.81 - $242.74 $126,004 - $154,625	637 Added 4.9%	13,641 $3.22 Million
Q1 2020 Apr 13, 2020	SELL	$182.24 - $241.7 $355,003 - $470,831	-1,948 Reduced 13.03%	13,004 $2.84 Million
Q4 2019 Jan 24, 2020	BUY	$189.21 - $243.2 $83,252 - $107,008	440 Added 3.03%	14,952 $3.6 Million
Q3 2019 Oct 15, 2019	SELL	$174.11 - $208.62 $8,009 - $9,596	-46 Reduced 0.32%	14,512 $2.81 Million
Q2 2019 Jul 10, 2019	BUY	$166.7 - $195.41 $792,158 - $928,588	4,752 Added 48.46%	14,558 $2.68 Million
Q1 2019 Apr 12, 2019	SELL	$180.87 - $203.88 $11,756 - $13,252	-65 Reduced 0.66%	9,806 $1.86 Million
Q4 2018 Jan 30, 2019	SELL	$178.4 - $208.25 $201,413 - $235,114	-1,129 Reduced 10.26%	9,871 $1.92 Million
Q3 2018 Nov 01, 2018	SELL	$185.29 - $208.89 $58,181 - $65,591	-314 Reduced 2.78%	11,000 $2.12 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $238,945 - $268,387	-1,439 Reduced 11.28%	11,314 $2.21 Million
Q1 2018 Apr 12, 2018	SELL	$169.43 - $198.0 $1.15 Million - $1.35 Million	-6,798 Reduced 34.77%	12,753 $2.17 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $677,860 - $757,377	4,016 Added 25.85%	19,551 $3.4 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $2.6 Million - $2.97 Million	15,535	15,535 $2.9 Million

Others Institutions Holding AMGN

# of Institutions

3,121

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $154B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.

Account

Valeo Financial Advisors, LLC Amgen Inc Transaction History